1 terminated, 1 withdrawn. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 1, Withdrawn 1 |
| Phase 1 | 1 | Withdrawn 1 |
Follow Arrhythmias: new trials by email Literature Review of Arrhythmias trials Research Report on Arrhythmias
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety of Phenylephrine Hydrochloride, Acetaminophen, Dimethindene Maleate Compared to Phenylephrine Hydrochloride Alone in Healthy Volunteers Phenylephrine HCL, Phenylephrine HCL/Acetaminophen/Dimethindene Maleate - Heart Rate, Blood Pressure | Phase 1 / Phase 2 | Withdrawn | Novartis | 2010-09-01 | 2016-03-03 | |
| Study Evaluating GAP-486 in Non-sustained Ventricular Tachycardia Double-blind investigational anti-arrhythmic, GAP-486 - Arrhythmias | Phase 2 | Terminated | Wyeth is now a wholly owned subsidiary of Pfizer | 500 | 2005-06-01 | 2022-05-03 |
Arrhythmias, Cardiac (2) · Systolic Murmurs (1)
Cardiovascular Diseases (2) · Heart Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Heart Murmurs (1) · Signs and Symptoms (1)
Dimethindene (1) · Oxymetazoline (1)
Novartis (1) · Wyeth is now a wholly owned subsidiary of Pfizer (1)
Brazil (2) · Canada (1) · Croatia (1) · Denmark (1) · Hungary (1) · India (1) · Italy (1) · Mexico (1) · Poland (1) · Romania (1) · Russia (1) · Serbia (1) · Sweden (1) · Ukraine (1) · United Kingdom (1)